EBE-A22

CAS No. 229476-53-3

EBE-A22( EBE-A22 | EBE A22 | EBEA22 )

Catalog No. M17448 CAS No. 229476-53-3

EBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 32 In Stock
10MG 46 In Stock
25MG 95 In Stock
50MG 142 In Stock
100MG 214 In Stock
200MG 300 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EBE-A22
  • Note
    Research use only, not for human use.
  • Brief Description
    EBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
  • Description
    EBE-A22 is a derivative of PD 153035. EBE-A22, has no effect on EGF-R TK but maintains a high cytotoxic profile. EBE-A22 binds to DNA and behave as typical intercalating agents. EBE-A22 unwinds supercoiled plasmid, stabilizes duplex DNA against heat denaturation, and produces negative CD and ELD signals, as expected for an intercalating agent. EBE-A22, but not PD153035, interacts preferentially with GC-rich sequences and discriminates against homooligomeric runs of A and T which are often cut more readily by the enzyme in the presence of the drug compared to the control.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    EBE-A22 | EBE A22 | EBEA22
  • Pathway
    Angiogenesis
  • Target
    FGFR
  • Recptor
    EGFR/ErbB1
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    229476-53-3
  • Formula Weight
    374.23
  • Molecular Formula
    C17H16BrN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL 133.61 mM; H2O : < 0.1 mg/mL
  • SMILES
    CN(c1cc(ccc1)Br)c1ncnc2cc(c(cc12)OC)OC
  • Chemical Name
    N-(3-bromophenyl)-6,7-dimethoxy-N-methylquinazolin-4-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Goossens JF, et al. DNA interaction of the tyrosine protein kinase inhibitor PD153035 and its N-methyl analogue. Biochemistry. 2001 Apr 17;40(15):4663-71.
molnova catalog
related products
  • Vofatamab

    Vofatamab (B-701) is a fully human monoclonal antibody targeting FGFR3. Vofatamab has potential anticancer and antitumor activity and is often used in combination with other compounds to treat cancer.

  • AG473

    AG473 is an inhibitor of EGFR in human A431 cells.Expressed the Ag473 lipoprotein from Neisseria meningitides, flagellin FlaB from Vibrio vulnificus and heat shock protein 70 from Mycobacterium tuberculosis (mHsp70) in Escherichia coli as single proteins and fusion proteins with VP2 protein of infectious bursal disease virus (IBDV).?

  • Sunitinib Malate

    Potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor.